Abstract
Agave has been used as a raw material for food and folklore medicinal purposes. Traditional processing involves the use of agave as a source of carbohydrate-rich syrups for direct use or as substrate to yield hydrolyzed fermented products and spirits. Agave plants can accumulate significant amounts of inulin, important molecule with prebiotic activity. The agave plant has been used to feed ruminants in arid areas where drought episodes are prevalent. This plant is an important source of saponins, considered as antinutritional factors but also as anticancer, antifungal, and antiinflammatory agents. Considering the low hydrosolubility of saponins, these compounds are not being recovered from the plant and alternative processes need to be devised. Agave also contains polyphenols with activities such as: anticancer, antioxidant, antidiabetic, anti-inflammatory, antiparasitical, antimicrobial, prebiotics and coadjuvant in mineral absorption. The full phytochemical characterization of the sap, leaves and byproducts generated from the traditional food uses is needed to validate the beneficial effects of agave consumption and its potential use as a source of functional ingredients.
Keywords: Agave, fructooligosaccharides, nutraceutical, polyphenols, saponins.
Current Bioactive Compounds
Title:Agave (Agave spp.) and its Traditional Products as a Source of Bioactive Compounds
Volume: 8 Issue: 3
Author(s): Liliana Santos-Zea, Ana Maria Leal-Diaz, Enrique Cortes-Ceballos and Janet Alejandra Gutierrez- Uribe
Affiliation:
Keywords: Agave, fructooligosaccharides, nutraceutical, polyphenols, saponins.
Abstract: Agave has been used as a raw material for food and folklore medicinal purposes. Traditional processing involves the use of agave as a source of carbohydrate-rich syrups for direct use or as substrate to yield hydrolyzed fermented products and spirits. Agave plants can accumulate significant amounts of inulin, important molecule with prebiotic activity. The agave plant has been used to feed ruminants in arid areas where drought episodes are prevalent. This plant is an important source of saponins, considered as antinutritional factors but also as anticancer, antifungal, and antiinflammatory agents. Considering the low hydrosolubility of saponins, these compounds are not being recovered from the plant and alternative processes need to be devised. Agave also contains polyphenols with activities such as: anticancer, antioxidant, antidiabetic, anti-inflammatory, antiparasitical, antimicrobial, prebiotics and coadjuvant in mineral absorption. The full phytochemical characterization of the sap, leaves and byproducts generated from the traditional food uses is needed to validate the beneficial effects of agave consumption and its potential use as a source of functional ingredients.
Export Options
About this article
Cite this article as:
Santos-Zea Liliana, Leal-Diaz Maria Ana, Cortes-Ceballos Enrique and Gutierrez- Uribe Alejandra Janet, Agave (Agave spp.) and its Traditional Products as a Source of Bioactive Compounds, Current Bioactive Compounds 2012; 8 (3) . https://dx.doi.org/10.2174/157340712802762410
DOI https://dx.doi.org/10.2174/157340712802762410 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Natural Products in Regression and Slowing of Progression of Atherosclerosis
Current Pharmaceutical Biotechnology Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases
Current Topics in Medicinal Chemistry A Multidisciplinary Atrial Fibrillation Clinic
Current Cardiology Reviews Long Term Ketamine and Ketamine Plus Alcohol Toxicity - What can we Learn from Animal Models?
Mini-Reviews in Medicinal Chemistry Interactions of Dietary Flavonoids with Proteins: Insights from Fluorescence Spectroscopy and Other Related Biophysical Studies
Current Drug Metabolism Editorial (Thematic Issue: Pharmacologic Strategies with Afterload Reduction in Low Cardiac Output Syndrome After Pediatric Cardiac Surgery)
Current Vascular Pharmacology Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Dynamic Changes in Phenotypic Groups in Patients with Stable Angina Pectoris after Treatment with Xinxuekang Capsule: A Randomized Controlled Trial
Current Vascular Pharmacology Left Atrial Appendage Closure -The WATCHMAN Device
Current Cardiology Reviews Analytical Procedures for Secondary Metabolites Determination: Recent Trends and Future Perspectives
Letters in Drug Design & Discovery 3D Printing as a Significant Achievement for Application in Posttraumatic Surgeries - A Literature Review
Current Medical Imaging Synthesis and Bioactivities of 2-Azetidinones as Cholesterol Absorption Inhibitors
Letters in Drug Design & Discovery Reactive Oxygen Species in the Initiation of IL-4 Driven Autoimmunity as a Potential Therapeutic Target
Current Pharmaceutical Design Omega-3 Polyunsaturated Fatty Acids and Cancer
Anti-Cancer Agents in Medicinal Chemistry MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK)
Current Pharmaceutical Design Non Alcoholic Fatty Liver: Epidemiology and Natural History
Reviews on Recent Clinical Trials Adhatoda vasica Nees: Phytochemical and Pharmacological Profile
The Natural Products Journal Predictors of Ominous Outcome in Infants who Undergo Cardiac Surgery and Cardiopulmonary By-Pass: S100B Protein
CNS & Neurological Disorders - Drug Targets Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits
Current Pharmaceutical Biotechnology Pharmacogenetics of HMG-CoA Reductase Inhibitors: Optimizing the Prevention of Coronary Heart Disease
Current Pharmacogenomics and Personalized Medicine